Mr. Chair, I have a couple of things I will say to that. The first is with respect to doses. We do have arrangements with the suppliers that if we need to push doses further back, we are able to do that.
The second thing, with respect to the cost, is to say the health and safety of Canadians was our top priority. We procured over 100 million doses, and every Canadian has the eligibility to have a full complement because of the strong procurement.